Selective late steroid withdrawal after renal transplantation. 2007

Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
Nephrology Unit, University Children's Hospital, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland. guido.laube@kispi.uzh.ch

Steroid withdrawal (SW) after paediatric renal transplantation (RTPL) is controversial. Selective late SW has been performed in our unit since 1995. The safety and effects of SW were analysed retrospectively in 47 patients undergoing RTPL between 1995 and 2004. Initial immunosuppression consisted of cyclosporine A, azathioprine or mycophenolate mofetil and steroids. Criteria for SW were: (1) stable renal function, (2) time interval after RTPL > or = 1 year, (3) no rejection or time interval after last rejection > or = 1 year and (4) good compliance. SW was performed in 30 patients at an age of 13.5 years (range 4.5-18.5) and 2.2 years (range 1-6.6) after RTPL. After SW, one patient experienced a steroid-sensitive rejection. Follow-up after SW (1.3 year; range 0.25-7.5) showed maintained renal function: glomerular filtration rate at SW and currently was 82 (65-128) and 82 (42-115) ml/min per 1.73 m(2), respectively. The number of patients on antihypertensive treatment did not significantly change (at SW: n = 15; currently: n = 11). Height and body mass index (BMI) remained stable: Median standard deviation score (SDS) for height/BMI at SW and currently was -1.1/0.2 and -0.8/0.1, respectively. Selective late SW was safe regarding renal function and had no significant effect on blood pressure and growth.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002657 Child Development The continuous sequential physiological and psychological maturing of an individual from birth up to but not including ADOLESCENCE. Infant Development,Development, Child,Development, Infant
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
April 1994, Clinical transplantation,
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
January 2018, Transplantation proceedings,
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
January 2006, Nephrology nursing journal : journal of the American Nephrology Nurses' Association,
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
January 2001, Transplantation proceedings,
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
March 2002, Transplantation proceedings,
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
November 2013, Pediatric nephrology (Berlin, Germany),
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
January 2001, Transplantation proceedings,
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
April 2018, Clinical transplantation,
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
January 2017, BMC medicine,
Guido F Laube, and Jutta Falger, and Markus J Kemper, and Andrea Zingg-Schenk, and Thomas J Neuhaus
February 2009, Pediatric nephrology (Berlin, Germany),
Copied contents to your clipboard!